Kymos Group, S.L offer service "Bioanalysis of Small Molecules"

Kymos Pharma Services develops and validates mass-spectrometry-based bioanalytical methods for innovative small molecules, having served as a trusted partner for companies from early project start-up through to market. Its scope spans in vitro/in vivo ADMET research, preliminary pharmacokinetics in early development, preclinical toxicokinetics/PK/PD across species, Phase I PK and dose-finding studies, and Phase II-IV biomarker and drug/food interaction analysis; supplied from Spain.